Image via Wikipedia
Promising results from a small study may offer hope for the treatment of multiple sclerosis (MS).
Researchers from the University of California – San Diego report dramatic improvement after treating MS patients with stromal vascular fraction (SVF) stem cells from a patient’s own body fat. They say the SVF therapy can limit the body’s immune system reaction and promote the growth of new myelin – the fatty “insulation” on axons in the brain, which breaks down in patients with MS.
“None of the presently available MS treatments selectively inhibit the immune attack against the nervous system, nor do they
Stem Cell Research Trial Results for Heart Disease Patients
Dr. Amit Patel of the University of Utah is reporting that 3 out of 3 heart disease patients have improved in the initial stages of his stem cell research trial in which the cardiomyopathy patients had their own Adult Stem Cells injected back into their heart in […]
Drug Companies and FDA Trying to Slow Adult Stem Cell Progress
In a startling new interview on stem cell research and adult stem cells in the near future, Dr. Christopher Centeno warns that Big Pharma and the FDA are teaming to control the use of a person’s own stem cells thus slowing innovation and the […]
Stem Cell Research Helps Girl With Autism
A woman from New York has written an open letter to Obama saying that stem cell research using Adult Stem Cells has helped her daughter’s autism. Judy DiCorcia is reporting that her daughter, Lauren, a 10 year old girl with autism has improved significantly after the stem cell […]
Joseph Wagner sees most cell-therapy companies offering little more than a bag of cells.
His company will give the bag a little direction.
Cell Targeting is developing technology that can point stem cell therapies to specific areas of the body. Among the many challenges in cell therapy is direction: not enough of the stem cells are getting to the tissues that needs treatment (…)
Currently a stem cell therapy can help different parts of the body. That attracts more customers, but doesn’t do much when the company wants to differentiate its product and charge a different price.
A stem cell therapy tweaked by